About Yuanshu

Founded in 2015 and headquartered in Nanjing, Yuanshu Pharmaceutical Technology Co., Ltd. is a National High-Tech Enterprise specializing in electronic materials while also engaging in the development of highly sophisticated pharmaceutical intermediates. The company has obtained ISO 9001 Quality Management System certification and has been recognized as a Jiangsu Private Technology Enterprise and recipient of the 'Jiangsu Excellent Technology' award. In 2020, the company was successfully listed on the Science and Technology Innovation Board of the Jiangsu Equity Exchange Center.

Based at the Jiangsu Life Science Innovation Park in Nanjing, the company has established a modern R&D center and an efficient technology platform dedicated to electronic chemicals. Its core product portfolio includes specialty modified epoxy resins, curing agents, accelerators, functional specialty materials, electroplating additives, and flame retardants. These products are widely applied in semiconductor packaging, high-frequency and high-speed copper clad laminates (CCL), high-performance composite materials, electronic encapsulation, and flame-retardant systems.

In the field of electronic materials, the company continuously focuses on molecular structure design, synthetic route optimization, and application performance evaluation, addressing key technical challenges related to purity, stability, compatibility, and environmental compliance of advanced electronic chemicals. Meanwhile, the company also maintains and advances its CRO/CDMO services for highly complex clinical pharmaceutical intermediates and ADC-related drug development, forming a dual-technology platform integrating electronic materials and pharmaceutical chemistry.

The company's R&D team possesses extensive expertise in process development and intellectual property management, implementing strict confidentiality and IP protection policies for all customized customer projects. To date, the company has been granted 21 invention patents, with 5 patents under examination and 11 additional invention patents filed and accepted.

Guided by the philosophy that 'technological innovation is the driving force of enterprise development', the company is committed to becoming a trusted supplier and long-term technology partner in the fields of electronic materials and fine chemicals.

Enterprise culture